The mineralocorticoid agonist fludrocortisone promotes survival and proliferation of adult hippocampal progenitors

Frontiers in Endocrinology

Volumn 7, Issue , 2016, Pages

  Gesmundo, Iacopo ^a   Villanova, Tania ^a   Gargantini, Eleonora ^a   Arvat, Emanuela ^a   Ghigo, Ezio ^a   Granata, Riccarda ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Amyloid beta peptide; Glucocorticoid receptor agonists; Hippocampal progenitor cell proliferation and survival; Hippocampal progenitors; Mineralocorticoid receptor agonists

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE 3; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; MAMMALIAN TARGET OF RAPAMYCIN; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRDU ASSAY; CAMP ASSAY; CELL PROLIFERATION; CELL SURVIVAL; DEGENERATIVE DISEASE; ENZYME ACTIVITY; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; MTT ASSAY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84992572185     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2016.00066     Document Type: Article

References (65)

1. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev (1998) 19:269-301. doi:10.1210/ edrv.19.3.0331
2. Van Eekelen JA, Jiang W, De Kloet ER, Bohn MC. Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J Neurosci Res (1988) 21:88-94. doi:10.1002/jnr.490210113
3. Arriza JL, Simerly RB, Swanson LW, Evans RM. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron (1988) 1:887-900. doi:10.1016/0896-6273(88)90136-5
4. Joels M, Karst H, Derijk R, De Kloet ER. The coming out of the brain mineralocorticoid receptor. Trends Neurosci (2008) 31:1-7. doi:10.1016/j. tins.2007.10.005
5. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science (1997) 275:661-5. doi:10.1126/science.275.5300.661
6. Nakagawa S, Kim JE, Lee R, Malberg JE, Chen J, Steffen C, et al. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci (2002) 22:3673-82.
7. Merz K, Herold S, Lie DC. CREB in adult neurogenesis - master and partner in the development of adult-born neurons? Eur J Neurosci (2011) 33:1078-86. doi:10.1111/j.1460-9568.2011.07606.x
8. Aberg MA, Aberg ND, Palmer TD, Alborn AM, Carlsson-Skwirut C, Bang P, et al. IGF-I has a direct proliferative effect in adult hippocampal progenitor cells. Mol Cell Neurosci (2003) 24:23-40. doi:10.1016/S1044-7431(03)00082-4
9. Peltier J, O'neill A, Schaffer DV. PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol (2007) 67:1348-61. doi:10.1002/dneu.20506
10. Gargantini E, Lazzari L, Settanni F, Taliano M, Trovato L, Gesmundo I, et al. Obestatin promotes proliferation and survival of adult hippocampal progenitors and reduces amyloid-beta-induced toxicity. Mol Cell Endocrinol (2016) 422:18-30. doi:10.1016/j.mce.2015.11.008
11. Hur EM, Zhou FQ. GSK3 signalling in neural development. Nat Rev Neurosci (2010) 11:539-51. doi:10.1038/nrn2870
12. Takei N, Nawa H. mTOR signaling and its roles in normal and abnormal brain development. Front Mol Neurosci (2014) 7:28. doi:10.3389/fnmol.2014.00028
13. Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M, Huttner HB, et al. Dynamics of hippocampal neurogenesis in adult humans. Cell (2013) 153:1219-27. doi:10.1016/j.cell.2013.05.002
14. Aimone JB, Li Y, Lee SW, Clemenson GD, Deng W, Gage FH. Regulation and function of adult neurogenesis: from genes to cognition. Physiol Rev (2014) 94:991-1026. doi:10.1152/physrev.00004.2014
15. Cameron HA, Gould E. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience (1994) 61:203-9. doi:10.1016/0306-4522(94)90224-0
16. Gould E, McEwen BS, Tanapat P, Galea LA, Fuchs E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci (1997) 17:2492-8.
17. Kim JB, Ju JY, Kim JH, Kim TY, Yang BH, Lee YS, et al. Dexamethasone inhibits proliferation of adult hippocampal neurogenesis in vivo and in vitro. Brain Res (2004) 1027:1-10. doi:10.1016/j.brainres.2004.07.093
18. Murray F, Smith DW, Hutson PH. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol (2008) 583:115-27. doi:10.1016/j.ejphar.2008.01.014
19. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron (2009) 62:479-93. doi:10.1016/j. neuron.2009.04.017
20. Brummelte S, Galea LAM. Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats. Neuroscience (2010) 168:680-90. doi:10.1016/j.neuroscience.2010.04.023
21. Garza JC, Guo M, Zhang W, Lu XY. Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3beta/beta-catenin signaling. Mol Psychiatry (2011) 17:790-808. doi:10.1038/mp.2011.161
22. Tanapat P, Hastings NB, Rydel TA, Galea LAM, Gould E. Exposure to fox odor inhibits cell proliferation in the hippocampus of adult rats via an adrenal hormone-dependent mechanism. JComp Neurol (2001) 437:496-504. doi:10.1002/cne.1297
23. Gomez-Sanchez CE, Gomez-Sanchez EP. The protective side of the mineralocorticoid receptor. Endocrinology (2012) 153:1565-7. doi:10.1210/ en.2011-2184
24. Gass P, Kretz O, Wolfer DP, Berger S, Tronche F, Reichardt HM, et al. Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice. EMBO Rep (2000) 1:447-51. doi:10.1093/embo-reports/kvd088
25. Berger S, Wolfer DP, Selbach O, Alter H, Erdmann G, Reichardt HM, et al. Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. Proc Natl Acad Sci U S A (2006) 103:195-200. doi:10.1073/pnas.0503878102
26. Munier M, Law F, Meduri G, Le Menuet D, Lombes M. Mineralocorticoid receptor overexpression facilitates differentiation and promotes survival of embryonic stem cell-derived neurons. Endocrinology (2012) 153:1330-40. doi:10.1210/en.2011-1436
27. Lai M, Horsburgh K, Bae SE, Carter RN, Stenvers DJ, Fowler JH, et al. Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur J Neurosci (2007) 25:1832-42. doi:10.1111/j.1460-9568.2007.05427.x
28. Crochemore C, Lu J, Wu Y, Liposits Z, Sousa N, Holsboer F, et al. Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry (2005) 10:790-8. doi:10.1038/sj.mp.4001679
29. Fischer AK, Von Rosenstiel P, Fuchs E, Goula D, Almeida OF, Czeh B. The prototypic mineralocorticoid receptor agonist aldosterone influences neurogenesis in the dentate gyrus of the adrenalectomized rat. Brain Res (2002) 947:290-3. doi:10.1016/S0006-8993(02)03042-1
30. Derijk RH, Wust S, Meijer OC, Zennaro MC, Federenko IS, Hellhammer DH, et al. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocrinol Metab (2006) 91:5083-9. doi:10.1210/ jc.2006-0915
31. Berardelli R, Karamouzis I, Marinazzo E, Prats E, Picu A, Giordano R, et al. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans. Eur J Endocrinol (2010) 162:1067-74. doi:10.1530/EJE-09-1076
32. Joshi YB, Chu J, Pratico D. Stress hormone leads to memory deficits and altered tau phosphorylation in a model of Alzheimer's disease. J Alzheimers Dis (2012) 31:167-76. doi:10.3233/JAD-2012-120328
33. Brureau A, Zussy C, Delair B, Ogier C, Ixart G, Maurice T, et al. Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model. Neurobiol Aging (2013) 34:1426-39. doi:10.1016/j.neurobiolaging.2012. 11.015
34. Benilova I, Karran E, De Strooper B. The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci (2012) 15:349-57. doi:10.1038/nn.3028
35. De Strooper B, Karran E. The cellular phase of Alzheimer's disease. Cell (2016) 164:603-15. doi:10.1016/j.cell.2015.12.056
36. Hinkelmann K, Wingenfeld K, Kuehl LK, Fleischer J, Heuser I, Wiedemann K, et al. Stimulation of the mineralocorticoid receptor improves memory in young and elderly healthy individuals. Neurobiol Aging (2015) 36:919-24. doi:10.1016/j.neurobiolaging.2014.09.008
37. Otte C, Wingenfeld K, Kuehl LK, Kaczmarczyk M, Richter S, Quante A, et al. Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals. Neuropsychopharmacology (2015) 40:386-93. doi:10.1038/ npp.2014.181
38. Johansson I, Destefanis S, Aberg ND, Aberg MA, Blomgren K, Zhu C, et al. Proliferative and protective effects of growth hormone secretagogues on adult rat hippocampal progenitor cells. Endocrinology (2008) 149:2191-9. doi:10.1210/en.2007-0733
39. Gallo D, Gesmundo I, Trovato L, Pera G, Gargantini E, Minetto MA, et al. GH-releasing hormone promotes survival and prevents TNF-alpha-induced apoptosis and atrophy in C2C12 myotubes. Endocrinology (2015) 156:3239-52. doi:10.1210/EN.2015-1098
40. Marini F, Pozzato C, Andreetta V, Jansson B, Arban R, Domenici E, et al. Single exposure to social defeat increases corticotropin-releasing factor and glucocorticoid receptor mRNA expression in rat hippocampus. Brain Res (2006) 1067:25-35. doi:10.1016/j.brainres.2005.10.002
41. Kagawa CM. Blocking the renal electrolyte effects of mineralocorticoids with an orally active steroidal spirolactone. Endocrinology (1960) 67:125-32. doi:10.1210/endo-67-1-125
42. Gould E, Cameron HA, Daniels DC, Woolley CS, McEwen BS. Adrenal hormones suppress cell division in the adult rat dentate gyrus. J Neurosci (1992) 12:3642-50.
43. Christ M, Gunther A, Heck M, Schmidt BM, Falkenstein E, Wehling M. Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells. Circulation (1999) 99:1485-91. doi:10.1161/01.CIR.99.11.1485
44. Massaad C, Houard N, Lombes M, Barouki R. Modulation of human mineralocorticoid receptor function by protein kinase A. Mol Endocrinol (1999) 13:57-65. doi:10.1210/mend.13.1.0226
45. Llorens-Martin M, Jurado J, Hernandez F, Avila J. GSK-3beta, a pivotal kinase in Alzheimer disease. Front Mol Neurosci (2014) 7:46. doi:10.3389/ fnmol.2014.00046
46. Crochemore C, Michaelidis TM, Fischer D, Loeffler JP, Almeida OF. Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation. FASEB J (2002) 16:761-70. doi:10.1096/ fj.01-0577com
47. Macleod MR, Johansson IM, Soderstrom I, Lai M, Gido G, Wieloch T, et al. Mineralocorticoid receptor expression and increased survival following neuronal injury. Eur J Neurosci (2003) 17:1549-55. doi:10.1046/j.1460-9568. 2003.02587.x
48. De Kloet ER, Otte C, Kumsta R, Kok L, Hillegers MH, Hasselmann H, et al. STRESS and DEPRESSION a crucial role of the mineralocorticoid receptor. J Neuroendocrinol (2016). doi:10.1111/jne.12379
49. Reul JM, Stec I, Soder M, Holsboer F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology (1993) 133:312-20. doi:10.1210/ endo.133.1.8391426
50. Rozeboom AM, Akil H, Seasholtz AF. Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc Natl Acad Sci U S A (2007) 104:4688-93. doi:10.1073/ pnas.0606067104
51. Kanatsou S, Fearey BC, Kuil LE, Lucassen PJ, Harris AP, Seckl JR, et al. Overexpression of mineralocorticoid receptors partially prevents chronic stress-induced reductions in hippocampal memory and structural plasticity. PLoS One (2015) 10:e0142012. doi:10.1371/journal.pone.0142012
52. Otte C, Jahn H, Yassouridis A, Arlt J, Stober N, Maass P, et al. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Life Sci (2003) 73:1835-45. doi:10.1016/S0024-3205(03)00513-7
53. Buckley TM, Mullen BC, Schatzberg AF. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls. Psychoneuroendocrinology (2007) 32:859-64. doi:10.1016/j.psyneuen.2007.05.016
54. Karamouzis I, Berardelli R, Marinazzo E, D'angelo V, Zinna D, Minetto MA, et al. The acute effect of fludrocortisone on basal and hCRH-stimulated hypothalamic - pituitary - adrenal (HPA) axis in humans. Pituitary (2013) 16:378-85. doi:10.1007/s11102-012-0435-3
55. Ishiguro H, Kawahara T, Zheng Y, Kashiwagi E, Li Y, Miyamoto H. Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity. Cancer Chemother Pharmacol (2014) 74:249-55. doi:10.1007/s00280-014-2496-7
56. Yeyeodu ST, Witherspoon SM, Gilyazova N, Ibeanu GC. A rapid, inexpensive high throughput screen method for neurite outgrowth. Curr Chem Genomics (2010) 4:74-83. doi:10.2174/1875397301004010074
57. Sasaki K, Yoshizaki F. Investigation into hippocampal nerve cell damage through the mineralocorticoid receptor in mice. Mol Med Rep (2015) 12:7211-20. doi:10.3892/mmr.2015.4406
58. Palmer TD, Markakis EA, Willhoite AR, Safar F, Gage FH. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J Neurosci (1999) 19:8487-97.
59. Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci U S A (2005) 102:19204-7. doi:10.1073/pnas.0507572102
60. Olijslagers JE, De Kloet ER, Elgersma Y, Van Woerden GM, Joels M, Karst H. Rapid changes in hippocampal CA1 pyramidal cell function via pre- as well as postsynaptic membrane mineralocorticoid receptors. Eur J Neurosci (2008) 27:2542-50. doi:10.1111/j.1460-9568.2008.06220.x
61. Yang S, Roselli F, Patchev AV, Yu S, Almeida OF. Non-receptor-tyrosine kinases integrate fast glucocorticoid signaling in hippocampal neurons. J Biol Chem (2013) 288:23725-39. doi:10.1074/jbc.M113.470146
62. Green KN, Billings LM, Roozendaal B, McGaugh JL, Laferla FM. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci (2006) 26:9047-56. doi:10.1523/JNEUROSCI. 2797-06.2006
63. Abraham I, Harkany T, Horvath KM, Veenema AH, Penke B, Nyakas C, et al. Chronic corticosterone administration dose-dependently modulates A beta((1-42))- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis. J Neuroendocrinol (2000) 12:486-94. doi:10.1046/j.1365-2826. 2000.00475.x
64. Goodman YD, Bruce AJ, Cheng B, Mattson MP. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem (1996) 66:1836-44. doi:10.1046/j.1471-4159.1996.66051836.x
65. Pedersen WA, McCullers D, Culmsee C, Haughey NJ, Herman JP, Mattson MP. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol Dis (2001) 8:492-503. doi:10.1006/nbdi.2001.0395